Cochrane News

Cochrane seeks Business Analyst - Deadline extended

2 years 11 months ago

Location: Flexible location (remote working) in the UK.
Specifications: Permanent contract.
Hours: Full-time week (flexible working considered) – 37.5 hours.
Salary: £40,000 per annum.
Application Closing Date: Monday 31 January (Midnight GMT).

This role is an exciting opportunity to use your problem-solving skills to make a difference in the field of health care research.  

As the Cochrane Library Business Analyst, you will gather, investigate, validate, and document business requirements using workshops, user research, user cases, and task and workflow analysis. You will ensure requirements are sufficiently detailed, reviewed, signed off, and kept up-to-date and are fully traceable. You will create and manage functional specifications, and contribute to identifying and validating appropriate solutions to support business objectives.

You will act as a key liaison between the relevant Cochrane stakeholders and departments, our publisher and their outsourced development vendor, to gather requirements, ensure that technical needs are well defined, that feature implementation goals are met, and that go-to-market activities are successfully performed.

Cochrane is a global, independent network of health practitioners, researchers, patient advocates and others, responding to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesizing research findings to produce the best available evidence on what can work, what might harm and where more research is needed. Our work is recognised as the international gold standard for high quality, trusted information.

  • For further information on the role and how to apply, please click here
  • The supporting statement should indicate why you are applying for the post, and how far you meet the requirements, using specific examples. Note that we will assess applications as they are received, and therefore may fill the post before the deadline.
  • Deadline for applications: Monday 31 January (Midnight GMT).
Tuesday, January 11, 2022 Category: Jobs
Lydia Parsonson

Cochrane International Mobility - Lea Styrmisdóttir

2 years 11 months ago

Cochrane is made up of 11,000 members and over 67,000 supporters come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, health professionals, patients, carers, people passionate about improving health outcomes for everyone, everywhere.

Getting involved in Cochrane’s work means becoming part of a global community. The Cochrane International Mobility programme connects successful applicants with a placement in a host Cochrane Group, learning more about the production, use, and knowledge translation of Cochrane reviews. The prgramme offers opportunities for learning and training not only for participants but also for host staff.

In this series, we profile those that have participated in the Cochrane International Mobility Program and learn more about their experiences.

Name: Lea Styrmisdóttir
Location:
Stockholm, Sweden
CIM location:
Cochrane Argentina


How did you first learn about Cochrane?
I first learned about Cochrane during my medical studies, the Cochrane Interactive Learning modules are an integrated part of the medical programme in Lund, Sweden.

What was your experience with Cochrane International Mobility?
I did a virtual exchange with Cochrane Argentina. I was part of writing a review on the effect of palivizumab, a monoclonal antibody, on respiratory syncytial virus (RSV) infection in children. This was also the subject of my master thesis. Through CIM, I took part in different webinars and trainings, learning more about the Cochrane methodology. I had a great experience with CIM and I am glad I had the opportunity to work with such driven and talented people.

What are you doing now in relation to your Cochrane International Mobility experience?
I presented my master thesis in January earlier this year. The review about palivizumab for RSV infection was recently published. I have continued my work at Cochrane Sweden after CIM and I am now working on another review about systemic opioid regimens for postoperative pain in neonates together with two other Cochrane members that previously have been a part of the CIM programme. I am also hoping to do more work with Cochrane in the future.  

Do you have any words of advice to anyone considering a Cochrane International Mobility experience?
If you are interested in evidence-based medicine and want to get to know other researchers around the world, you should definitely take part in the CIM programme!

Monday, December 13, 2021
Lydia Parsonson

Covidence seeks Community Manager - remote, Asia-Pacific region

2 years 11 months ago
  • Full-time, Part-time or  flexible arrangement
  • Remote work with at least a 4 hour workday crossover with the AEST timezone
  • AUD$60,000 - $80,000 full time base salary (or paid pro rata for parttime)

Launched in 2014, Covidence is a world leading SAAS platform that enables health and science research teams to rapidly synthesise and uncover actionable insights from the mountains of existing research in the world. Their mission is to dramatically improve lives by changing the way the world creates and uses knowledge. 

They are seeking to grow their global user engagement and support team with a Community Manager based in the Asia-Pacific region. To excel as a Community Manager, you will have excellent interpersonal skills, strong written and verbal communication skills, and be highly organised with proven ability to appropriately prioritise tasks and deliver on time in a busy environment. You will have demonstrated capacity to work independently and with others in a globally distributed team. And importantly, you’ll have proven ability working with online technologies and social media.

 

Monday, December 6, 2021 Category: Jobs
Muriah Umoquit

Cochrane Pain, Palliative and Supportive Care Review Group seeks Managing Editor (maternity cover) DEADLINE EXTENDED

2 years 11 months ago

Main area: Editorial; Evidence Based Medicine; Research
Grade: NHS AfC: Band 7
Contract: Fixed term: 9 months (The length of the contract is dependent on the start date; this is a maternity cover position, with the post-holder returning in October 2022)
Hours: Full time - 37.5 hours per week (Part-time hours considered)
Job ref: 321-CORP-MAED-B7
Site: Home-based
Salary: £40,057 - £45,839 Dependent on experience
Closing date: 04/01/2022 23:59
Interview date: 06/01/2022

We would like to invite applications for a Managing Editor (maternity cover) with the Cochrane Pain, Palliative and Supportive Care Review Group (PaPaS CRG). A Managing Editor is responsible for the day-to-day operational management of the CRG editorial base. The ideal applicant will be educated to degree level or above, with managerial, administrative, scientific or publishing experience or equivalent, along with excellent organisational and communication skills. Knowledge of scientific and medical terminology and evidence-based health care is desirable. Familiarity with clinical trials, systematic reviews, or Cochrane would be welcomed.

  • This is a full-time remote (home-working) role until October 2022; part-time hours can be considered.
  • The closing date is 06 January.
  • For more information and how to apply, please visit this page
Monday, December 6, 2021
Lydia Parsonson

Launch of Evidence Essentials 5: Consumer involvement in Cochrane

2 years 11 months ago

New online learning is now freely available about Consumer involvement in Cochrane as part of its Evidence Essentials modules.

Cochrane is delighted to announce the launch of a new module Consumer involvement in Cochrane as part of its  Cochrane Evidence Essentials free, online learning.

Written from the perspective of a healthcare consumer and co-created with patients and carers, this learning is for anyone interested in finding out about getting involved in Cochrane, as a patient, a carer, or member of the public (what Cochrane calls consumers).



Topics included in the module include a 'Welcome to Cochrane' section, a description of the different ways to contribute to systematic reviews evidence and to Cochrane, and how to sign-up to get involved. The learning is interactive, with quizzes, animations, and ways to check your knowledge.

This module is the latest in Cochrane’s “Evidence Essentials” that gives an introduction to Evidence Based Medicine, clinical trials, systematic reviews and how to use evidence when making decisions about your health. The modules have been visited over 35,000 times since their launch, and have now been translated into German and Russian, with other languages to follow.

Cochrane’s Consumer Engagement Officer, Richard Morley welcomed the launch of the latest module:



“Cochrane has a long history and commitment to involvement and engagement as an essential part of producing trusted evidence that can be used in making informed decisions and improving health. This latest module in the Evidence Essentials series has been co-designed and produced with consumers and puts into one exciting place all the information you might want to know in order to be a part of our growing global community.”

Lynn Laidlaw and Sally Crowe who facilitated the engagement process and wrote the initial content based on feedback from patients, carers and public, said: “We are very pleased that the final version launched today represents much of the discussion over two workshops.  We feel that this module is more attuned to people that may never have heard of Cochrane before, but are curious and potentially interested in getting involved in the production of Cochrane evidence”.



There are five interactive modules that make up Evidence Essentials: an introduction to Evidence Based Medicine, Randomized Controlled Trials, Introduction to systematic reviews, Understanding and using systematic reviews and the latest, Consumer involvement in Cochrane. The learning journey is led by Eleni, a fictional consumer.

Thursday, December 9, 2021
Lydia Parsonson

Cochrane makes statement to special session of the World Healthy Assembly

2 years 11 months ago

A World Health Assembly special session to discuss the development of a potential new global health treaty to support pandemic preparedness is taking place this week (29 November – 1 December).

The World Health Assembly is the decision-making body of the World Health Organization (WHO) and is attended by representatives of all Member States.

Our statement, which reiterates the reflections from the recent Cochrane Convenes meetings about the COVID-19 evidence response, is below:

Cochrane is a global advocate for evidence-informed health and health care. Our mission is to produce relevant and timely synthesized evidence.

Building and strengthening systems which are adequately prepared to produce and use reliable, relevant and timely evidence will be crucial to respond to future global health emergencies.

Cochrane recently hosted a convening of high-level stakeholders, co-sponsored by WHO, to reflect on the role of evidence in the COVID-19 pandemic and develop recommendations for future preparedness. The evidence response has been inequitable; our research methods, tools and processes have been pushed to their limits; and we have struggled to communicate uncertainties and gain trust.

Therefore, we urge Member States to ensure that any convention or instrument developed during this process prioritise the production, use and communication of evidence – and is accompanied by sustained investment in the systems and people who perform this vital role.

Our recommendations echo the WHO Evidence-informed Policy Network call for action, which we proudly support.

Tuesday, November 30, 2021
Muriah Umoquit

Cochrane seeks Support Officer

2 years 11 months ago

Location: Flexible location (remote working) – contract type dependent on location.
Specifications: 1 Jan to 31 July 2022. Fixed-term contract if successful applicant based in UK, Germany or Denmark. Consultancy contract in other locations.
Hours: Part time 22.5 hours per week.
Salary: £30,000 per annum (pro-rated to part time).
Application Closing Date: Monday 13 December (Midnight GMT).

This role is an exciting opportunity to use your communication and problem-solving skills to make a difference in the field of health care research.  

The Cochrane Support team is the first point of contact for the international Cochrane community. We provide technical and user support to Cochrane editorial teams and review authors; and handle enquiries from members of the public about Cochrane’s work.

We pride ourselves on our timely and coordinated support service, covering a broad range of areas including Cochrane review-writing software, editorial processing and publication, Cochrane Account login, membership, training, and volunteering opportunities.

The team works closely with Cochrane’s Central Editorial Service and Editorial and Methods Department, as well as IT Services, to ensure accurate, consistent responses to queries on Cochrane technology, policies and methods.

Cochrane is a global, independent network of health practitioners, researchers, patient advocates and others, responding to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesizing research findings to produce the best available evidence on what can work, what might harm and where more research is needed. Our work is recognised as the international gold standard for high quality, trusted information.

For further information on the role and how to apply, please click here.  The supporting statement should indicate why you are applying for the post, and how far you meet the requirements, using specific examples. Note that we will assess applications as they are received, and therefore may fill the post before the deadline.

  • Deadline for applications: Monday 13 December (12 midnight GMT)
  • Interviews to be held on: w/c 20 December 2021 (times to be confirmed)
  • If you have any questions or would like an informal chat about the role please contact Lorna via recruitment@cochrane.org
  • Apply here
Monday, November 29, 2021 Category: Jobs
Lydia Parsonson

Cochrane International Mobility - Raphaela Mayerhofer

2 years 11 months ago

Cochrane is made up of 11,000 members and over 67,000 supporters come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, health professionals, patients, carers, people passionate about improving health outcomes for everyone, everywhere.

Getting involved in Cochrane’s work means becoming part of a global community. The Cochrane International Mobility programme connects successful applicants with a placement in a host Cochrane Group, learning more about the production, use, and knowledge translation of Cochrane reviews. The prgramme offers opportunities for learning and training not only for participants but also for host staff.

In this series, we profile those that have participated in the Cochrane International Mobility Program and learn more about their experiences.

Name: Raphaela Mayerhofer
Location:
Stockholm, Sweden
CIM location:
Cochrane Austria

How did you first learn about Cochrane?
Cochrane is a household name in my field, it must have been many years ago when I first heard about it

What was your experience with Cochrane International Mobility?
Even though my stay at Cochrane Austria was only four weeks long, I learned incredibly much. To make the most of my time, the team made sure I could join ongoing projects right away. I had the chance to participate in ongoing systematic reviews and rapid reviews, and work on projects assessing evidence synthesis methods. CIM gave me the opportunity to sharpen my skills and fueled my enthusiasm for evidence synthesis.

What are you doing now in relation to your Cochrane International Mobility experience?
I’m currently preparing a workshop to share what I learned with faculty members at my university.

Do you have any words of advice to anyone considering a Cochrane International Mobility experience?
Find a Cochrane Center that specializes in what interests you to make the most of it!

Wednesday, November 24, 2021
Lydia Parsonson

Cochrane seeks Director of Development

2 years 11 months ago

Specifications: Full Time (Permanent)
Salary: £85,000 per annum
Location: Flexible
Application Closing Date:  19 December 2021

Cochrane is a global, independent network of health practitioners, researchers, patient advocates and others, responding to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesizing research findings to produce the best available evidence on what can work, what might harm and where more research is needed. Our work is recognised as the international gold standard for high quality, trusted information. An understanding of Cochrane’s work and health research more generally is an advantage, but not essential.

We are now looking to recruit our first Director of Development, whose role will be to work with the global community to grow our fundraising income substantially in the coming years.  As a member of the executive leadership team, they will lead the Development Directorate and establish a fundraising operation that works collaboratively to deliver significant global income growth.

Key to success in this role will be the development and implementation of fundraising, marketing, communications, and engagement and influencing strategies – as well as understanding and ideally experience of international fundraising. As such, we are seeking an ambitious and creative individual who relishes a challenge, loves collaborative working, delivers results and has extensive experience of successfully delivering strategy.

The majority of Cochrane Central Executive staff are located in London, UK, however flexible location and/or working arrangement are possible for the right candidate.

How to apply
For further information on the role and how to apply, please click here.  The deadline to receive your application is by 19 December 2021.  The supporting statement should indicate why you are applying for the post, and how far you meet the requirements, using specific examples.

First interviews likely to be held week beginning 10 January 2022

Tuesday, November 23, 2021 Category: Jobs
Lydia Parsonson

The Centre for Epidemic Intervention Research seeks researchers - Oslo, Norway

3 years ago

The Centre for Epidemic Intervention Research at the Norwegian Institute of Public Health, located in Oslo, Norway,  is currently seeking applicants for the following positions:

The overall mission for the newly established centre is to produce more and better evidence on the effects of public health and social interventions, and non-pharmacological infection control measures, specifically. This also includes adverse consequences. The centre will collaborate with researchers, institutions, organisations, and stakeholders both nationally and internationally. The centre works closely with the World Health Organization's intiative to strengthen the evidence base for decisions about public health and social measures.

Application deadline 15 December 2021.

Friday, November 19, 2021 Category: Jobs
Muriah Umoquit

Using patient questionnaires for improving clinical management and outcomes

3 years ago

In this interview with lead author Christopher Gibbons, we find out more about the recently published review,  Routine provision of information on patient-reported outcome measures to healthcare providers and patients in clinical practice.

Tell us about this review
The aim of this Cochrane Review was to find out whether healthcare workers who receive information from questionnaires completed by their patients give better health care and whether their patients have better health. We collected and analysed all relevant studies.

What did you find out?
Patient questionnaire responses fed back to health workers and patients may result in moderate benefits for patient\provider communication and small benefits for patients' quality of life. Healthcare workers probably make and record more diagnoses and take more notes. The intervention probably makes little or no difference for patient's general perceptions of their health, social functioning, and pain. There appears to be no impact on physical and mental functioning, and fatigue. Our confidence in these results is limited by the quality and number of included studies for each outcome.

What was studied in the review?
When receiving health care, patients are not always asked about how they feel, either about their physical, mental or social health. This can be a problem as knowing how the patient is feeling might help to make decisions about diagnosis and the course of the treatment. One possible solution is to ask the patients to complete questionnaires about their health, and then give that information to the healthcare workers and to patients.



What are the main results of the review?
We found 116 studies (49,785 participants), all of which were from high income countries. We found that feeding back patient questionnaire responses to healthcare workers and patients probably slightly improves quality of life and increases communication between patients and their doctors, but probably does not make a lot of difference to social functioning. We are not sure of the impact on physical and mental functioning or fatigue of feeding back patient questionnaire responses as the certainty of this evidence was assessed as very low. The intervention probably increases diagnosis and note taking. We did not find studies reporting on adverse effects defined as distress following or related to Patient reported outcomes measures (PROM) completion.
 
What would you like to see happen next to provide more evidence in this area?
I would like to see more large, high quality, cluster randomized clinical trials that increase the evidence base for the intervention that use Computerized Adaptive Testing in the measurement of patient reported outcomes. In these interventions, the information which is fed-back combines standardized and individualized measurement, these randomize patients and clinicians to different modalities of feed-back interventions and recipients (including patient only, patient and professional, professional only).

Outcomes of interest include:

  • adverse effects
  • general health perceptions,
  • specific symptoms, (cough, insomnia, nausea, anorexia, constipation, diarrhoea),
  • clinicians ratings of severity,
  • counselling,
  • different types of visits, admissions and their length,
  • patient physician relationship,
  • unmet patient needs,
  • quality of care and costs;
  • and that focus on people with multimorbidity

Further research on the mechanisms by which the intervention operates is needed.

Wednesday, November 24, 2021
Lydia Parsonson

Vaccines for preventing rotavirus diarrhoea: an updated Cochrane review

3 years ago

The latest update of the Cochrane review ‘Vaccines for preventing rotavirus diarrhoea: vaccines in use’ has found that rotavirus vaccines pre-qualified by the World Health Organization (WHO) (Rotarix, RotaTeq, Rotasiil, and Rotavac), prevent episodes of rotavirus diarrhoea in children and no increased risk of serious adverse events was found.

Rotavirus infection is a common cause of diarrhoea in infants and in young children, and can cause mild illness, hospitalization, and death. Since 2009, the WHO has recommended that a rotavirus vaccine be included in all national infant and child immunization programmes. To date, 107 countries have followed this recommendation. In the years before infants and children started receiving rotavirus vaccine, rotavirus infection resulted in about 0.5 million deaths per year in children under five years of age, mainly in low- and middle-income countries.

This Cochrane Review, processed by the Cochrane Infectious Diseases Group (CIDG) editorial base at Liverpool School of Tropical Medicine, was first published in 2004 and has been updated five times. In 2012, in consultation with the WHO, the data underwent major restructuring by country mortality rates to reflect the observation that vaccine efficacy profiles are different in countries with different mortality rates.

The 2012, 2019, and 2021 review updates were preceded by systematic reviews commissioned by the WHO Immunization, Vaccines & Biologicals department and were used for WHO policy decisions on rotavirus vaccination schedules. These reviews were carried out by members of the author team and the subsequent Cochrane review updates built on the WHO reviews and vice versa.

The most recent review includes 60 studies: Rotarix (36 trials), RotaTeq (15 trials), Rotasiil (5 trials), and Rotavac (4 trials). The findings were presented at Session 6 - Rotavirus Vaccines at the October 2020 SAGE Meeting and was provided to SAGE Members as key background material to inform discussions (access presentation and background materials here).  As a result of this SAGE discussions, an updated WHO Rotavirus Vaccine Position Paper was published on 16 July 2021).  This position paper provides global advice on rotavirus vaccine policy.  In turn, the updated WHO position paper and the supporting background materials support Regional and National Immunization Technical Advisory group discussions which lead to decisions for local rotavirus vaccine policies.



Lead author, Hanna Bergman, noted, “The two globally established vaccines already have a proven track record and we now have high confidence in the two newer vaccines, all showing similar efficacy in preventing severe rotavirus diarrhea in infants and young children in high-mortality settings. This review also reinforces that more work needs to be done to improve and explore the reasons behind the lower efficacy of rotavirus vaccines seen in high-mortality countries.”

Bergman H, Henschke N, Hungerford D, Pitan F, Ndwandwe D, Cunliffe N, Soares‐Weiser K. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database of Systematic Reviews 2021, Issue 11. Art. No.: CD008521. DOI: 10.1002/14651858.CD008521.pub6.

The editorial base of the Cochrane Infectious Diseases Group is funded by UK aid from the UK government for the benefit of low- and middle-income countries (project number 300342-104). The views expressed do not necessarily reflect the UK government’s official policies.

Thursday, November 18, 2021
Lydia Parsonson

Measures implemented in the school setting to contain the COVID-19 pandemic: a rapid review

3 years ago

This review provides insight into the effectiveness of measures implemented in the school setting to contain the COVID-19 pandemic.

While there are limitations to this review, the review demonstrates that a range of different measures can be effective at reducing COVID-19 transmission, especially when multiple interventions are implemented together. Importantly, the review demonstrates that schools can stay open (or reopen) safely when prevention measures are implemented effectively. The effectiveness of interventions is influenced by many things, including the levels of community transmission. Given the rapid and widespread advancements in prevention and containment measures, most notably, the COVID-19 vaccines and increases in testing capacity, as well as the rise of more transmissible variants of the virus, an update to this review may yield very different results.

What was studied in the review?
In order to reduce the spread of the virus that causes COVID-19, many governments and societies put mitigation measures in place in schools. However, we do not know whether these measures work with regards to reducing the spread of the virus, or how these measures affect other aspects of life, such as education, the economy or society as a whole.

Key messages
Reopening schools or keeping schools open while having a broad range of measures in place can reduce transmission of the virus that causes COVID-19. Such measures can also reduce the number of people who will need to go to hospital due to developing COVID-19. However very little is known about other consequences of these measures, such as those linked to education, resources, and physical or mental health, as this knowledge is mostly based on studies modelling the real world. More studies set in the real world using real-world data are needed.

Lead author Shari Krishnaratne explains:

“This review provides insight into the effectiveness of measures implemented in schools to contain the COVID-19 pandemic. Whilst the review addresses a very important question there are limitations to the evidence it provides. We searched for studies for the review in December 2020, at a time when there was a lack of real-world evidence. As such, most of the studies included in this review use modelling. This review therefore shows an overall absence of real-world evidence about the effectiveness of these measures. However, there is enough evidence from the modelling studies and in other reviews such as one on travel measures for us to have some confidence that there is likely to be a positive effect on transmission, but how an intervention works in one location might not be the same as in another.
 
There are limitations to the evidence, but it does suggest that schools can stay open (or reopen) safely when prevention measures are implemented effectively. The effectiveness of interventions is influenced by many things, including the levels of community transmission. Given the rapid and widespread advancements in prevention and containment measures, most notably, the COVID-19 vaccines and increases in testing capacity, as well as the rise of more transmissible variants of the virus, an update to this review may yield very different results.”

What are measures implemented in the school setting?
Measures in the school setting can be grouped into the following four broad categories.

  1. Measures reducing the opportunity for contacts: by reducing the number of students in a class or a school, opening certain school types only (for example primary schools) or by creating a schedule by which students attend school on different days or in different weeks, the face-to-face contact between students can be reduced.
  2. Measures making contacts safer: by putting measures in place such as face masks, improving ventilation by opening windows or using air purifiers, cleaning, handwashing, or modifying activities like sports or music, contacts can be made safer.
  3. Surveillance and response measures: screening for symptoms or testing sick or potentially sick students, or teachers, or both, and putting them into isolation (for sick people) or quarantine (for potentially sick people).
  4. Multicomponent measures: measures from categories 1, 2 and 3 are combined.

What is the aim of the review?
The authors aimed to find out which measures implemented in the school setting allow schools to safely reopen, stay open, or both, during the COVID-19 pandemic.

What did we do?
They searched for studies that looked at the impact of these types of measures in the school setting on the spread of the virus that causes COVID-19, the impact on the healthcare system (i.e. how many hospital beds are needed), as well as important social aspects (i.e. how often students attended school). The studies could focus on students, teachers and other school staff, as well as on families and the whole community. They could use real-life data (observational studies) or data from computer-generated simulations (modelling studies).

View the video in German, French, or Spanish

What are the main results of the review?
The authors found 38 relevant studies. Most of these were modelling studies (33 studies). Five studies used real-world data. Twenty studies were conducted in North or South America, 16 in Europe and two in China.

Below we summarise the main findings by category.

  1. Measures reducing the opportunity for contacts
    The authors found 23 modelling studies assessing measures to reduce the opportunity for contacts. All studies showed reductions in the spread of the virus that causes COVID-19 and the use of the healthcare system. Some studies also showed a reduction in the number of days spent in school due to the intervention.
  2. Measures making contacts safer
    The authors found 11 modelling studies and two real-world studies looking at measures, such as mask wearing in schools, cleaning, handwashing, and ventilation. Five of these studies combined multiple measures, which means we cannot see which specific measures worked and which did not. Most studies showed reductions in the spread of the virus that causes COVID-19; some studies, however, showed mixed or no effects.
  3. Surveillance and response measures
    We found 13 modelling studies and one real-world study assessing surveillance and response measures. Twelve studies focused on mass testing and isolation measures, while two looked specifically at symptom-based screening and isolation. Most studies showed results in favour of the intervention, however some showed mixed or no effects
  4. Multicomponent measures
    They found three studies that looked at multicomponent interventions, where it was not possible to determine the effect of each individual intervention. These included one modelling study and two real-world studies. These studies assessed physical distancing, modification of activities, cancellation of sports or music classes, testing, exemption of high-risk students, handwashing, and face masks. Most studies showed reduced transmission of the virus that causes COVID-19, however some showed mixed or no effects.

How confident are we in the findings of this review?
Confidence in these results is limited. Most studies used models, that is, they estimated the effects of the interventions rather than observing outcomes. As the models are built on assumptions about how the virus spreads and how people behave, we lack real-world evidence. Many studies were published as 'preprints' without undergoing rigorous checks of published studies, which further limits confidence. Also, the studies were very different from each other (for example, with regards to the levels of transmission in the community).

How up to date is this evidence?
The evidence is up-to-date to December 2020. It is expected this review will be updated in Spring 2022.

Monday, January 17, 2022
Lydia Parsonson

Special Collection - Influenza: evidence from Cochrane Reviews

3 years ago

Cochrane Library Special Collections provide a round-up of up-to-date Cochrane evidence on a specific topic. This Special Collection contains Cochrane Reviews summarizing data on the benefits and harms of several interventions for preventing and treating influenza. The Cochrane Reviews look at  vaccines, antiviral drugs, and physical interventions, such as the use of masks and hand washing.

This evidence for physical interventions may help inform policies and practices relevant to the ongoing COVID-19 pandemic. These comprehensive reviews provide valuable information for patients, doctors, and healthcare decision-makers about what steps to take or interventions to use to prevent influenza or aid its treatment.

Thursday, December 9, 2021
Muriah Umoquit

2021 Journal Impact Factor for Cochrane Database of Systematic Reviews is 12.008

3 years 4 months ago

The 2021 Journal Citation Report has been released by Clarivate Analytics, and we are delighted to announce that the Journal Impact Factor for the Cochrane Database of Systematic Reviews (CDSR) is now 12.008. This is an increase on the 2020 Journal Impact Factor, which was 9.289.

The CDSR Journal Impact Factor is calculated by taking the total number of citations in a given year to all Cochrane Reviews published in the past two years and dividing that number by the total number of Reviews published in the past two years. While Journal Impact Factor is a useful measure of average citation frequency, we recognize that it is not the only measure of success or impact.  

Some highlights from the CDSR 2021 Journal Citation Report:

  • CDSR is ranked 19th of the 172 journals in the Medicine, General & Internal category
  • CDSR received 92,845 cites in the 2021 Journal Impact Factor period, compared with 81,212 in 2020 
  • The 5-Year Journal Impact Factor is 11.956 compared with 9.871 in 2020

Cochrane Library’s Editor in Chief, Karla Soares-Weiser, commented: “I am delighted to see a rise in Impact Factor for the Cochrane Database of Systematic Reviews. Cochrane’s efforts to publish high quality reviews on COVID-19 have clearly made an impact, as several of these make up our top 20 cited reviews for 2021. All of these data demonstrate the continuing usage and impact of Cochrane Reviews and reflect enormous credit on our many thousands of contributors and groups.”

 

Thursday, June 30, 2022
Muriah Umoquit

Cochrane speaks with the Science Basement Podcast

3 years 6 months ago

The Science Basement Podcast is a podcast hosted by young scientists and scientists-in-training who share their excitement about science and science communication. They have conversations with scientists and other guests with the aim of making complicated ideas understandable to non-scientists, while showing why science matters.

Here we highlight some episodes where they talked to people in the Cochrane Community: 

Let's talk about an epidemic of misinformation Episode 5 with Anastasiia & Eleanna with guest Tiffany

Tell us if you are not confused when you scroll your newsfeed or change TV channels and see a whole array of opinions on each and every topic. One example you can probably relate to is the COVID crisis: vaccines or no vaccines, masks or no masks - which information is true? Who should we listen to in the end?

 

The name of this problem is “infodemic”. It means just what you think it means. In this episode, we are talking to Tiffany Duque, a senior advisor at Cochrane, about infodemic, expanding to the topic of misinformation in research and how to manage it.

In 2021, they spoke with members of Cochrane over three episodes:

Episode 1 - Cochrane Reviews in times of COVID-19 with Dr John Lavis

Tomàs Garnier  Artiñano and  Lea Urpa interview Dr. John Lavis. John is a member of the Cochrane editorial board, member of the Cochrane knowledge-translation advisory group, and founder and director of the McMaster Health Forum, which hosts COVID-END. John speaks about what we know about COVID-19 so far, the importance of evidence synthesis and Living Systematic Reviews, how the media covers science, and Cochrane's Plain Language Summaries, translation work, and how Cochrane works with patients and careers. 

 Episode 2 -  Systematic Reviews: How do scientists collect information? 

Giuliano Didio and Elmo Saarentaus discuss with the Cochrane Reveiwer Fiona Stewart about what is a systematic review and... how to make one. Fiona is a Network Support Fellow for Cochrane, an international not-for-profit organisation for independent health care research. She has over ten years of experience working in health services research and has published several systematic reviews on topics ranging from pregnancy to urinary incontinence to obesity. Fiona explains what a systematic review is, how we involve the public in our work, how our plain language summaries makes our evidence accessible, and the importance of our knowledge transfer and translation work. 

Episode 3 - How can we assess scientific information?

In this episode Eleanna Asvestari & Katja Kaurinkoski discuss with Jack Nunn the importance of making science accessible and how to assess critically all the information around us. Jack  is the founder and Director of the non-for-profit education organisation Science for All, and co-creator of ‘Standardised Data on Initiatives (STARDIT), a PhD researcher at the Department of Public Health at La Trobe University,  recently appointed member of the Cochrane Consumer Network Executive and part of  Cochrane's Advocacy Advisory group.

Learn more about the Science Basement podcast by following them on Facebook, Instagram, or Twitter. 

Tuesday, August 15, 2023
Muriah Umoquit

The Cochrane Library App

3 years 8 months ago

Monthly issues will cease after Issue 12 (December), 2021. All downloaded content will continue to be available within the app.

Thank you to everyone who has downloaded and read Cochrane Reviews via the app.

The Cochrane Library App presents the latest up-to-date evidence from the Cochrane Library in a convenient, easy to navigate format which provides you with relevant, accessible research, when you need it, from the world’s leading experts in evidence-informed health care.

All content in the app is free and new issues will download regularly.

Our monthly issues feature a hand-picked selection of Cochrane Systematic Reviews, specifically chosen by the Editor-in-chief.  Abridged Cochrane Reviews provide the best possible tablet and phone reading experience and they are downloadable for reading offline. The Bookmark feature allows you to create your own special collection of Cochrane Reviews across issues. Additionally, the title page for every review includes a link to the full version of the review available on the Cochrane Library.

Hello, and welcome to the December 2021 issue of the Cochrane Library app.

This month’s edition covers a variety of topics including exercise-based cardiac rehabilitation for coronary heart disease, decision coaching for making healthcare decisions, rehabilitation for older people with hip fractures, antiemetics to prevent nausea and vomiting caused by chemotherapy,  antibiotics for hospital-acquired pneumonia in neonates and children, prevention of dementia and cognitive decline, nonsteroidal anti-inflammatory drugs for women undergoing breast surgery, and vitamin C supplementation for prevention and treatment of pneumonia.

Our main review this month is ‘Vaccines for preventing rotavirus diarrhoea: vaccines in use’. Rotavirus is a common cause of diarrhoea, diarrhoea‐related hospital admissions, and diarrhoea‐related deaths worldwide. Authors from the Cochrane Infectious Diseases Group evaluated rotavirus vaccines prequalified by the WHO for their efficacy and safety in children.

The abridged versions of these reviews are available in this issue. Visit www.cochranelibrary.com to read the full versions.

Our monthly issues produced exclusively for the app feature a hand‐picked selection of Cochrane Systematic Reviews, specifically abridged to provide the best possible mobile reading experience. You can create your own special themed collection of Cochrane Reviews across issues in the app on topics such as occupational health by using the app’s Bookmark feature.

The title page for every review included in this and previous issues includes a link to the full version of the review available on the Cochrane Library at www.cochranelibrary.com

Friday, December 17, 2021
Muriah Umoquit

Cochrane community participates in a virtual walk to raise money for Anne Anderson Award

3 years 8 months ago

The global Cochrane community are walking and raising money for the annual Anne Anderson Award, which is given to a Cochrane member who has contributed meaningfully to the promotion of women as leaders and contributors to the organization.

Who is Anne Anderson?
Anne Anderson was a contributor to the stream of thinking and effort that gave birth to evidence-based health care. A clinically qualified reproductive physiologist, Anne had an active interest in women’s health, co-editing the first edition of Women’s Problems in General Practice with Ann McPherson and contributed to Effectiveness and Satisfaction in Antenatal Care (1982), edited by Murray Enkin and Iain Chalmers. She was discussing with Marc Keirse and Iain Chalmers the possibility of co-editing a companion volume on elective birth, however her premature death from breast cancer in 1983 ended her involvement. Anne Anderson was 46 years old when she died. Iain Chalmers, Murray Enkin and Marc Keirse went on to publish Effective Care in Pregnancy and Childbirth (ECPC) in 1989, dedicating the book in part to Anne. ECPC, through its systematic approach to assessing the research literature, is widely acknowledged to have led to development of Cochrane. 

What is the Cochrane Anne Anderson Award?
In the footsteps of Anne Anderson, many outstanding women continue to contribute and inspire other women to improve health knowledge for the good of their communities. Often these women are quiet achievers who might otherwise not be recognized. The goal of the Anne Anderson Award is to recognize and stimulate individuals contributing to the enhancement of women’s visibility and participation in the Cochrane leadership. The award is given to a Cochrane member who has contributed meaningfully to the promotion of women as leaders and contributors to the organization. 

The Anne Anderson Award winner receives a plaque from Cochrane honouring her contributions, as well as a cash award. The recipient designates the cash award to assist a woman from a low-resource setting with Cochrane activities.

What's the Anne Anderson Walk?
The Cochrane Colloquium, our annual flagship event, brings together the world’s most influential health researchers, scientists, academics, opinion leaders, clinicians, and patients to promote evidence-informed decision-making. It is here that the award is given out and the fundraising walk is held. The annual Anne Anderson Walk is a cherished annual social event, where attendees explore the Colloquium host-city by foot with a guide. Donations by participants are made to next year's Anne Anderson Award. 

Given current COVID-19 circumstances, Cochrane community's will be not be gathering in 2022 for a Colloquium. However, we are walking  together virtually and sharing pictures of our walks.

How can I participate?
All Cochrane Members and Supporters are welcome to participate in this virtual walk and fundraising effort! 

Thursday, February 10, 2022
Muriah Umoquit

Cochrane International Mobility

4 years 1 month ago

Getting involved in Cochrane’s work means becoming part of a global community. Connect with Cochrane Groups across the world through the Cochrane International Mobility programme!

The Cochrane International Mobility programme builds on previous successful student exchanges involving Cochrane Centres around the world. A broader initiative involving multiple Cochrane Groups has  been launched by Cochrane People Services Department.

Successful applicants will complete a placement in a host Group, learning more about the production, use and knowledge translation of Cochrane reviews.

Gain skills and experience

Arrangements are flexible and placements can vary in length, depending on the project plan. Placements are typically self-funded. Participants completing postgraduate study have benefitted from university funding, and some Groups can offer work space or accommodation. Training and mentoring support is offered in different areas, specific to Groups' expertise.

Learn from each other

Cochrane International Mobility offers opportunities for learning and training not only for participants but also for host staff. Cochrane Croatia welcomed a student intern as part of the fledgling programme.

“I’m very grateful to Cochrane Croatia for hosting me and for this wonderful experience, and I’m sure I’ll be using all the skills I learned as I continue on in my academic career,” said Sarah Tanveer, Cochrane International Mobility participant, Summer 2019.

Tina Poklepović Peričić, Co-director, Cochrane Croatia added, “This was an encouraging experience for us all, and spending time with Sarah, exchanging experiences, teaching and working with her was a true refreshment to our Centre.”

Apply now

Find out more about the programme on Cochrane Training or search for opportunities on Cochrane Engage.

Read profiles of participants



 

 

Tuesday, October 29, 2024
Muriah Umoquit

#MyCochraneStory

4 years 3 months ago

Cochrane's strength is in its collaborative, global community.  Our 100,000+ members and supporters from more than 130 countries work together to produce credible, accessible health information and help inform health decision making. Though we are spread out across the globe, our shared passion for health evidence unites us. 

We want to come together and tell our collective and individual Cochrane stories!
To share your #MyCochraneStory please contact support@cochrane.org with the following:

  • A photo: At your desk, at Cochrane event, or a headshot.
  • Your country of residence: Our community is diverse and we want to celebrate this!
  • Your Cochrane Story: We want to hear about what Cochrane work and achievements you are most proud of! 3-4 sentences about yourself and your story and any URLs that could be included.
  • Social media handles: We will give your Twitter or Instagram account a tag; just let us know your handles!

 Phil Käding, from Germany, first learned of Cochrane when studying pharmacy. Since joining Cochrane's volunteer platform, Cochrane Engage, he has contributed to numerous translation projects and provided consumer feedback on several Cochrane reviews. Phil has also been an active participant on the citizen science platform, Cochrane Crowd, and has attended Cochrane Training webinars and seminars. He sees his involvement in Cochrane as playing an important role in directing his academic path towards clinical drug development and trials (Good Clinical Practice) and is now pursuing postgraduate studies in this field. Phil especially appreciates the inclusive and collaborative nature of Cochrane, involving patients, professionals, and scientists from different backgrounds. He encourages anyone interested in evidence-based medicine, regardless of speciality, to get involved!

 Jessica D’Urbano, from Italy, is currently studying Occupational and Space Medicine in Friuli-Venezia Giulia. She loves both patient interaction and solitary research and scientific writing. Along with spending time with her daughter, Jessica volunteers for Violawalkhome,  an international project supporting people in danger walking on the street. As a proud Cochrane Member, Jessica values Cochrane's role as a global reference for healthcare workers and patients. Engaged in the Cochrane US Mentoring Program with a mentor and cohort of six mentees, she actively contributes to the citizen science platform Cochrane Crowd and undertakes interesting volunteer tasks on Cochrane Engage.  Jessica recommends both platforms for their opportunities to contribute to real research, learn about evidence synthesis, and find enjoyment in the process!  

Anthony Uwandu-uzoma, from Nigeria, based in United Kingdom, holds a degree in Medicine and Surgery and a Masters in Public Health.  He is a research assistant in a University of Bolton project, focusing on the mental health experiences of nursing and pre-registration nursing students in the UK. With a mentoring background spanning over 50 Public Health Masters students, Anthony shares his expertise through his blog that helps train students in public health data analysis, epidemiology, health promotion, and critical writing skills. An enthusiastic Cochrane contributor, Anthony actively participates in the citizen science platform, Cochrane Crowd. He also dedicates time to tasks within our volunteer hub, Cochrane Engage. In 2023, Anthony was selected to participate as a mentee in the Cochrane US Mentoring Program. Anthony actively contributes to these Cochrane initiatives, as he feels it underscores his unwavering dedication to upholding the rigorous methodology and research standards for which Cochrane is renowned. 


Sowmyashree Hanumantha Setty, from India, is a second-year master's student at Tufts University School of Engineering majoring in Biomedical Engineering. Tufts University is a Cochrane US Affiliate Centre. Under the mentorship of Dr. Shayesteh Jahanfar, Sowmyashree discovered her passion for impactful research after undertaking the Cochrane Standard Author Training. In addition to her role as a Teaching Assistant in systematic review courses, Sowmyashree has contributed to reviews on pregnancy and childbirth and pioneered initiatives like "Incorporating Equity, Diversity, and Inclusion into Cochrane Systematic Reviews with AI" alongside Dr. Jahanfar. Sowmyashree draws immense inspiration from collaborating with her Cochrane colleagues. She is eager to persist in her current work, contribute to additional reviews, and embark on leading her own project in the future. For Sowmyashree, Cochrane represents the gold standard of systematic reviews and a community that fosters growth and personal development - it's where passion meets impact! 

Jheng-Yan Wu, a dietitian hailing from Taiwan, has been actively involved with Cochrane since 2018, when he first encountered the principles of evidence-based medicine and Cochrane's work. Their dedication led them to become a Cochrane Supporter in 2021 by translating evidence from English to Traditional Chinese. In 2022,  Wu embarked on a personal challenge of learning about the methodology behind systematic reviews and conducting meta-analyses. He fully immersed himself in the Cochrane Handbook, diligently absorbing valuable techniques along the way. The commitment was so profound that he decided to get the Cochrane logo on his arm as a cherished tattoo, serving as a constant reminder to apply his acquired knowledge in clinical practice. This act symbolizes his unwavering passion and aspiration to one day publish in the prestigious Cochrane Database of Systematic Reviews.

Karina Tapinova, discovered Cochrane during her medical school courses on pharmacology and epidemiology and began using Cochrane Reviews to uncover evidence on commonly used medical products in her country, Kazakhstan. To her surprise, she learned that many home remedies relied on by her family and local clinicians had no scientific evidence of benefit to support their use. After completing her studies, she began working as a research assistant at her university and is now responsible for writing systematic reviews. As Karina delved deeper into the Cochrane Collaboration, having completed its interactive modules, using the Cochrane Handbook, and participating in educational webinars, she became a volunteer translator for Cochrane Russia and took on tasks through Cochrane Crowd, which greatly expanded her knowledge. In summer 2022, Karina was fortunate to participate in the US Cochrane Mentorship program - a wonderful opportunity that she never could have imagined during her medical school days. As a mentee of Cochrane Russia, she began working on translating into Russian and recording Cochrane podcasts with her husband, Eugene, and as of 2023, she started editing translations of the Plain Language Summaries of Cochrane Reviews, prepared by volunteer translators. Karina is also currently involved in organizing international webinars. To her, the Cochrane Collaboration represents not only a gold standard of systematic reviews, but also a community of incredible people, opportunities for growth, and personal development.

Rosnani Zakaria, a family medicine specialist and medical lecturers at Universiti Sains Malaysia in Kelantan, Malaysia. She graduated from St. Andrews University and The University Of Manchester in late 1990 and early 2000s and completed family physician training from Academy of Family Physician Malaysia & RACGP in 2012. Rosnani started to get involved in editing Malay PLS with Cochrane Malaysia in 2015 and loved the experience, as Community education is her passion. Rosnani is also a researcher in several medical fields.

Marwa Badawy, from Egypt has a Bachelor's degree in Medicine and Surgery and is now a General practitioner at Ministry of Health in Egypt. Marwa is an active researcher and a scientific writer with four publications and more to come! When the Cochrane Mentorship program opened, it ignited fire in her to be part of Cochrane family, to join this prestigious research association to learn from her professors and to make good connections. She participated with four projects with her amazing mentor: Dr. Jahanfar and learned alot. Marwa also has successfully passed the Cochrane Systematic Review Standard Author training, and is also a volunteer at Cochrane Crowd in the "Covid Quest Lite" Project, screening more than 100 papers.She is working right now on a new Cochrane project in the public health field with her mentor, Dr. Jahanfar, on a review in screening, and will work on analysis and writing with her. Marwa is enthusiastic to work in Cochrane as her long term plan.

Ahmed Azam, from Egypt is a highly motivated physiotherapy researcher involved in clinical research since his early years in school. Ahmed uses his research skills in methodology and statistics, and has two years experience in conducting clinical research and meta-analysis models to evaluate the safety and efficacy of novel treatments. He developed a model for medical student research in Egypt, provided the evidence synthesis workshops for trainees in 2021, and currently maintains a bi-annual clinical research training for Arab doctors with +400 people benefiting from the training. Ahmed first joined Cochrane in December 2020 when he signed up for Cochrane Crowd. Within days, he classified more than 5,000 records with 95% accuracy, and earned four Cochrane Crowd badges. He also completed the newcomer and student pathways. Ahmed first earned his Cochrane membership in December 2020 until 2027 and is proud to continue to be a Cochrane member.

Jyothsna Kuriakose, from India, is an early career professional specializing in the field of palliative medicine pertinent to oncology. Her areas of special interest include research methodologies in palliative care and complex symptom management. The first ever encounter she had with Cochrane was as a postgraduate student when she had to present Cochrane reviews relevant to palliative care for the departmental journal clubs in the hospital. Since then, it was her dream to work with Cochrane. She has had the opportunity to do a peer review for the Cochrane PaPaS group. A proud member of Cochrane since July 2022, she is one of the mentees in the Cochrane US Mentoring Program Year 2 (2022-2023). She is excited to be a part of this platform and is looking forward to learning from and contributing to the many works of Cochrane.

Paola Andrenacci from Argentina has worked as a nutritionist for more than 20 years, specializing in liver diseases and is passionate about evidence-based nutrition, dissemination and translation of knowledge. Paola is a participant in the inaugural Cochrane US Mentor Program. As a collaborator of Cochrane Nutrition, Paola was invited to participate in the writing of Prioritization exercise: WHO evidence-based guide for nutrition and in the translation from English to Spanish of 14 nutrition summaries for the Cochrane Nutrition Newsletters. Through Tiffany Duque, she received a full scholarship for WHO/Cochrane/Cornell Summer Institute (training completed in July 2022). She also had the opportunity to complete another training at Tufts University School of Medicine (affiliate of Cochrane US)  and training was completed in October 2022. Paola was co-chair for International Women's Day  and is now the coordinator of the Cochrane US Mentoring Program Y2 as well as program mentor and mentee at the same time! Finally, Paola was accepted to be part of the ExME (S4BE in Spanish) dissemination committee and author of the blog.

Esra Bilir, from Turkey, is a gynecology and obstetrics resident in Germany. She completed the “Gender Studies Certificate Program” at The Center for Gender Studies at Koc University, Turkey and “Postgraduate Certificate in Epidemics and Ethical Global Health” at AUSN, USA. She also attained MSc in Data Science. Currently, she is pursuing MSc in Global Health. Her research focuses on gynecologic oncology, research methodology, and biostatistics. Since medical school, she is inspired by high-quality research and evidence-based medicine. Dr Bilir has been proud to hold  Cochrane Membership since August 2022. She is currently a mentee in Year 2 (2022-2023) Cochrane US Mentoring Program. She is thrilled to join this extraordinary cohort of people around the globe and to work with Cochrane experts to further improve her skills in research methodology. Dr Bilir is looking forward to a productive future with the Cochrane team. 

Moriasi Nyanchoka, from Kenya, has a background in Public Health Nutrition and is a researcher interested in global public health. He is passionate about evidence synthesis in global health and its utilisation to inform policy and decision-making. He is also interested in knowledge translation, communication, and dissemination of research synthesis. Moriasi joined Cochrane in April 2022 when he signed up for Cochrane Crowd, our Citizen Scientist platform. He has classified 11,096 records, participated in 4 Global screening challenges, and earned 12 Cochrane Crowd badges. He earned his Cochrane Membership in June 2022 and is proud to be a Cochrane Member. Moriasi is currently a mentee in the Cochrane US Mentoring Program. He is excited to join the Year 2 (2022-2023) Mentorship cohort and thrilled to work with Cochrane mentors to further his skills in evidence synthesis and contributions.

Mohammed K. Al-Haggagi is an Egyptian physical therapist and researcher interested in neuroscience, neurorehabilitation, biomechanics, and electrophysical agents. He is passionate about knowledge, scientific methodology, and continuous learning in order to provide the best treatment for patients. He joined Cochrane for the first time in September 2021, when he signed up for Cochrane Crowd. He had classified 5000 records, and he soon earned five Cochrane Crowd badges and completed the newcomer and student pathways. Among these is the gold badge in clinical trial identification, which he earned with 100% accuracy. He first earned his Cochrane membership in July 2022, and is proud to continue to be a Cochrane member. The Cochrane Task Exchange was the door that turned him to the Early Career Professional network. This opportunity has helped him collaborate with researchers across the globe whom he only knew by their names from their books and papers. He now has his own international research team, leads about 6 other research teams in different medical schools, works on many papers (systematic reviews and meta-analysis, cross-sectional studies, CT, ... etc), and has given him access to invaluable training resources. He is proud to be a Cochrane member.

Santiago Castiello-de Obeso was raised in Guadalajara, Jalisco, Mexico but now resides in Oxford, UK. He recalls the first time he heard about Cochrane when a friend told him that vitamin C did not prevent the common cold. He enquired into this and his friend explained what a meta-analysis was. Santiago was astonished at the idea of combining all studies into one and realised how much sense that made. Inspired by this, Santiago started working on a Cochrane review with Cochrane Schizophrenia and was part of the inauguration of Cochrane Mexico. Santiago is currently Chair of the Early Career Professional Network. He is certain that whatever the future holds, Cochrane will be there.

Nelly Darbois is a French physiotherapist and science writer. For the past 3 years, she has been writing articles on rehabilitation for patients and caregivers, based on Cochrane reviews. Her website receives up to 45,000 visits/month. Nelly a contributor to Cochrane Crowd and Cochrane France and she also edits Wikipedia pages based on Cochrane reviews.

Cheng Hsien Hung, from Taiwan, works in a regional hospital, and specializes in adverse drug reaction assessment and pharmacist education. He was first introduced to the Cochrane Systematic Reviews in 2017 when learning Evidence-Based Medicine. Since 2018, he learned critical appraisal of randomized controlled trials and non-randomized controlled trials through the Cochrane Taiwan course and tried to apply what he learned in clinical practice. In 2021, he participated in an Evidence-Based Medicine promotion activity held by Cochrane Taiwan and received positive feedback on his use of interesting memes to promote Cochrane Systematic Reviews. He has been learning many valuable skills through Cochrane and hopes to use high-quality Cochrane reviews to help more people in the future.

Mojtaba Keikha, is an Iranian researcher, and PhD student in Epidemiology at Kerman University of Medical Sciences. He is a member of Cochrane Trainers Network and a member of Cochrane Iran. Motjaba collaborated as a facilitator, mentor and coordinator in several Cochrane workshops in Iran. He is the author of two Cochrane articles published in the Cochrane Database of Systematic Reviews and also does tasks in Cochrane Crowd and Cochrane Task Exchange.

Fatemeh Mirzaei, from Iran, is a 6th-grade dental student at Golestan University of Medical Sciences. She joined Cochrane in February 2022, starting her activity in Cochrane Crowd, our citizen scientist platform. In less than one month, her contributions granted her full Cochrane membership. She has earned 9 badges, contributed to 6 tasks, and has earned over 1,671 membership points. When she took part in the "HPV vaccination programme" and "The COHeRe Project" challenges, she screened more than 300 records!

Pratibha Mary Thomas, from India is working as an Assistant Professor of Physical therapy. Her specialization and area of expertise is in Musculoskeletal Disorder and Sports and she also volunteers as a manuscript reviewer in various International journals. Prathibha started her journey with Cochrane in March 2022 and progressed through each step of making her contribution to Cochrane by being associated with the Cochrane Crowd activities and from being a Supporter to earning a Cochrane membership. The Cochrane Crowd activities helped her to a great extent in gaining comprehensive knowledge especially regarding RCT's, which are considered as a gold standard of evidence. The Health Evidence with Cochrane Evidence Essentials section provided Pratibha with valuable insights on how to utilize and apply evidence into practice, so that she could deliver the best treatment options to her patients. Along with all these, being an academician, Cochrane served as a guiding tool of how to impart research knowledge to her students. Pratibha has now contributed to 7 tasks, earned 9 badges, participated in the global challenge on "COVID Quest Lite" and also participated in the Screen4Me challenge by the Metabolic and Endocrine Disorders group.

Nila Pillai, comes from a midwifery background with three grandchildren. She first got into Cochrane back in 2012 through a research project, the SEA URCHIN project, using Cochrane evidence to reduce neonatal infection. After the research project she was invited to take on the position of Cochrane Support Coordinator for Cochrane Malaysia and her main role has been managing their translation initiative,  Ringkasan Cochrane Bahasa Malaysia.  She has been doing this for 7 years. Nila really enjoys working with the volunteer translators and editors who have responded amazingly to the project and she credit the success of the project to them. She's proud to be a part of the Cochrane Malaysia team!

Paul Ogongo, from Kenya is a Research Scientist in Pathogen Immunobiology program at the Institute of Primate Research, Nairobi, Kenya. He joined Cochrane in 2013 after being introduced by his colleague Dr. Jael Obiero. Paul's first involvement was as a peer reviewer with Cochrane Infectious Diseases group  for the review, ‘’Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas.’’ in 2013. Paul has been an author with Cochrane STI group of the updated review, “Topical microbicides for preventing sexually transmitted infections” and another registered review, “Nifuratel-Nystatin combination for the treatment of mixed infections of bacterial vaginosis, vulvovaginal candidiasis, and trichomonal vaginitis.” Paul's areas of research are immunology and diagnostics of infectious diseases. Currently, and his research focuses on human T cell immune responses to Mycobacterium tuberculosis infection. He is excited about the networking and mentorship opportunities that comes with being a member of Cochrane and thrilled at the birth of the newest member of the Cochrane family, Cochrane Kenya.

Jael Apondi Obiero, from Nairobi, Kenya, is a Senior Research Scientist in reproductive health at the Institute of Primate Research, where she uses nonhuman primates as models for preclinical research. Jael first heard about Cochrane Reviews in 2007 at a Research Methods Course on Randomised Trials, Systematic Review Method and Good Clinical Practice organised by the Effective Care and Research Unit in East London, South Africa. She thereafter proceeded to register her first Cochrane review, “Topical microbicides for preventing sexually transmitted infections” with the Sexually Transmitted Infections Review Group. This review published in 2012, and we published an update in 2021. Jael registered her second Cochrane Review title “Nifuratel-Nystatin combination for the treatment of mixed infections of bacterial vaginosis, vulvovaginal candidiasis, and trichomonal vaginitis” with the same review group thereafter, and in 2015, she received the Aubrey Sheiham Evidence-Based Healthcare in Africa Leadership Award from Cochrane to conduct this Cochrane Review. She has mentored other Cochrane authors in her region, and is happy to have used her Cochrane experience to contribute to the birth of the newest Cochrane baby on the globe, Cochrane Kenya, which is launching in June 2021

Julián Balanta-Melo, from Colombia, is an Assistant Professor at the Universidad del Valle School of Dentistry. As a Specialist in Oral Rehabilitation (Prosthodontics), he has implemented the Evidence-Based Dentistry principles in his clinical practice and his preclinical/clinical teaching since 2010. In 2018, during the final year of his PhD training in dental sciences in Chile, he was introduced to Cochrane by Professor Julio Villanueva Maffei, and performed his training in the Cochrane Associate Centre based in the Universidad de Chile Faculty of Dentistry. In 2020, he peer-reviewed two intervention reviews from the Cochrane Oral Health Group, a new one regarding the control of dental aerosols in clinical settings and one update about oral hygiene care for critically ill patients, both of priority interest during the ongoing COVID-19 pandemic. As a scientist, he is interested in the mammalian craniofacial bone biology and the impact of several clinical interventions on its homeostasis, from a translational research approach. Linked to his research interest, he is currently the first author of an ongoing Cochrane Systematic Review (protocol stage) with the Cochrane Movement Disorders Group from Portugal. His priorities in Colombia include the improvement of both the access to and the understanding of the high-quality evidence among clinicians, students/residents and patients, with the outstanding support of Cochrane Colombia and the Ibero-American Cochrane network.

Peter Gichuhi Mwethera, from Nairobi, Kenya, joined Cochrane in 2007 after being introduced by Prof. Charles Wiysonge and authoring a review for Cochrane STI. He currently works at a Primate Research Centre in Nairobi called the Institute of Primate Research (IPR) as a Senior Research Scientist in Reproductive Health. IPR is a premier biomedical primate institute whose mandate is to improve health by ethically utilizing the non-human primates. It is a WHO collaborating Institute and is also aaalac accredited. He also runs a company called Medicals Africa Limited, which administers reproductive health products that we developed, patented, and commercialized as a result of his research over the last 14 years. He is very passionate about reproductive health issues because reproductive health is one of the most neglected aspects of human health. His Cochrane review, Topical microbicides for preventing sexually transmitted infections, was updated in 2021. Following the outbreak of Covid pandemic, his institution was designated a Covid testing centre by the Kenyan Government, and he was appointed to coordinate the testing.

Nkengafac Villyen Motaze, from Cameroon, attended his first training on Cochrane reviews in 2010, organized by the Effective Care Research Unit in East London, South Africa. He proceeded to register his first Cochrane title in 2011, a few months prior to enrolling for his masters in Epidemiology. His first Cochrane review was published in 2013, and it served as his masters project. Ten years later, he has published several systematic reviews, facilitated about a dozen training sessions, and mentored novel authors in low- and middle-income countries. He has peer-reviewed Cochrane reviews for Effective Practice and Organization of Care and the Pregnancy and Childbirth review groups, and he is a member of the Cochrane Africa Network. As he prepares for his PhD graduation, which is coming up in a couple of months, he is embarking on an update of his first Cochrane review, while taking up further mentorship roles to ensure continuity and contribute to increasing the number of Cochrane authors on the African contintent.

Anelisa Jaca, a Postdoctoral Research Fellow based in the South African Medical Research Council, Cochrane South Africa, is a Medical Scientist by qualification. She did her MSc and PhD around cancer research specifically focusing on determining the biological pathways that contribute towards the development and progression of colon and stomach malignancies. After obtaining her PhD, she transitioned to Evidence-based Medicine, where she learnt about methods used to synthesise medical research evidence, important for making healthcare decisions and policy. Her current area of focus at Cochrane South Africa is on vaccine implementation research, around the factors that drive vaccine hesitancy in South Africa. She is also interested in fighting against the burden of cervical cancer through addressing Human papillomavirus (HPV) vaccine hesitancy in the South African context. 

Meghan Bohren, based in Australia, is a Senior Research Fellow in Gender and Women’s Health at the University of Melbourne and an Editor with Cochrane Effective Practice and Organisation of Care (EPOC). She was first introduced to Cochrane whilst  a PhD student and working with Metin Gülmezoglu at the WHO Department of Sexual and Reproductive Health and Research. At the time they were exploring how to better integrate qualitative evidence into WHO guidelines, in order to better understand people’s values, preferences and experiences of healthcare, as well as factors affecting implementation of interventions or models of care. Claire Glenton and Simon Lewin mentored Meghan in this space, and she was excited to join Cochrane Effective Practice and Organisation of Care as an editor in 2015. Meghan sat down with the Cochrane Early Career Professionals (ECP) group and shared some thoughts as part of the #WhereAreTheyNow series.

Alicia Aleman is currently based in Uruguay and works with the Cochrane Collaborating Group of Uruguay. She became aware of the Cochrane Library in 1995 when she was doing an internship at the Centro Latinoamericano de Perinatología, a center associated with the Pan American Health Organization/World Health Organization (PAHO/WHO). That year, the director of the center began promoting the use of scientific evidence in perinatal and  obstetric clinical practice and the use of the Cochrane Library in clinical decision-making. Since then, Alicia has been involved in teaching evidence-based medicine and in 2002, started her first Cochrane review (Bed rest during pregnancy for preventing miscarriage). After that, she continued working from the Faculty of Medicine (of which Alicia is an Associate Professor in the Department of Preventive and Social Medicine), giving courses in Evidence-Based Medicine, systematic reviews and clinical practice guidelines. In 2009, the Uruguayan Cochrane Group was created (coordinated by Dr. Oscar Gianneo) within the Ibero-American Cochrane network and in 2012 she did an internship at the IberoAmerican Cochrane Center.  Alicia is a contributor to the Uruguayan Cochrane group, giving courses, supporting translations, and collaborating with the active search programs for randomized studies published in Uruguay. Alicia sat down with the Cochrane Early Career Professionals (ECP) group and shared some thoughts as part of the #WhereAreTheyNow series in English and Spanish

Amr Elsareih, from Egypt, is a physical therapist interested electrophysical agents, especially electrical stimulation in neurological physical therapy, neurorehabilitation, and evidence-based practice. He first joined Cochrane in December 2019 when he signed up for Cochrane Crowd. Within days, he had classified more than 1000 records, and he soon earned eight Cochrane Crowd badges and completed the newcomer and student pathways. Among these is the purple badge in clinicial trial identification, which he earned with 99% accuracy. He's participated in Screen 4 Me classification for two systematic reviews. He first earned his Cochrane membership in January 2020, and is proud to continue to be a Cochrane member!

Matthew Page, from Australia, is a Senior Research Fellow at the School of Public Health and Preventive Medicine, Monash University. He is also a Co-Convenor of the Cochrane Bias Methods Group. In the final months of Matthew's undergraduate degree in psychology, he decided he should get some work experience for a year, before returning to study as a clinical neuropsychologist. Matthew saw an ad for a research assistant position at what was then the Australasian Cochrane Centre (now Cochrane Australia) and went for it, having taken an interest in meta-analysis during his psychology degree. Lucky for him, he got the job, started working there in 2008, fell in love with systematic review methodology, and gave up on his initial plan so he could focus on developing the science of how to conduct and report systematic reviews optimally. Matthew sat down with the Cochrane Early Career Professionals (ECP) group and shared some thoughts as part of the #WhereAreTheyNow series. 

Celeste Naude is currently based in South Africa. She is the Co-Director of Cochrane Nutrition and an Associate Editor with Cochrane Effective Practice and Organisation of Care (EPOC). Celeste is a mid-career professional and sat down with the Cochrane Early Career Professionals (ECP) group and shared some thoughts as part of the #WhereAreTheyNow series.  Celeste credits her introduction to and involvement with Cochrane to Prof Jimmy Volmink who introduced her to evidence synthesis research and the field of evidence-based health care. Jimmy, who was the Director of Cochrane South Africa at that point, invited Celeste to assist in a project called Supporting Policy-relevant Reviews and Trials (SUPPORT). At that time, the Cochrane EPOC satellite in Norway was coordinating efforts to produce SUPPORT Summaries of all low- and middle-income-relevant EPOC reviews and to make them freely available online. From there, Celeste joined an author team on a Cochrane review, and was subsequently involved in establishing and launching Cochrane Nutrition in 2016, the only Field hosted in a low and middle-income country. Celeste sat down with the Cochrane Early Career Professionals (ECP) - learn more and read her advice.

Cristian Herrera is currently based in France and Spain and is an Associate Editor for the Effective Practice and Organization of Care (EPOC) group and an editor in the Chilean EPOC satellite. When Cristian was a fifth year medical student, he joined a recently created health policy and systems research team at the P. Universidad Católica de Chile that was working on a Cochrane review. This connected him with the world of Cochrane and with the EPOC Group through a larger project led by a team from the Norwegian Knowledge Centre for the Health Services (this team is currently working in the Norwegian Institute of Public Health). So, starting out as an author was his entrance door to Cochrane. Cristian sat down with the Cochrane Early Career Professionals (ECP) - learn more and read his advice. Read in English and Spanish.

Zohra Lassi is a NHMRC Early Career Research Fellow at the University of Adelaide and a Feedback Editor with Cochrane Acute Respiratory Infections Group. She was first introduced to Cochrane Systematic Reviews while working as a Research Fellow at the Aga Khan University, Pakistan under the mentorship of Prof Zulfiqar Bhutta. Her very first Cochrane Systematic Review was with Cochrane Pregnancy and Childbirth Group on “Community based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes”. Zohra's first review led her to receive the Kenneth Warren Prize from  Cochrane for preparing a review of high methadological quality and relevant to health problems in developing countries. Since then, she has prepared more than 15 Systematic Reviews and Protocols.  

Jesse Uneke, from Nigeria, is the Director and Founder of the African Institute for Health Policy and Health Systems, Ebonyi State University, Nigeria. Jesse is also an Associate Editor with the Effective Practice and Organisation of Care (EPOC) group. Jesse was introduced to Cochrane by Dr Simon Lewin and got involved with the Cochrane Nigeria Centre. Jesse sat down with the Cochrane Early Career Professionals (ECP) - learn more and read his advice.

Joshua Vogel, from Australia, is a Principal Research Fellow at the Burnet Institute and an Associate Editor with Cochrane Pregnancy and Childbirth.  Joshua was first introduced to Cochrane & Cochrane Reviews while a PhD student. He had the good fortune to be working under Metin Gülmezoglu at the Department of Sexual and Reproductive Health and Research at WHO in Geneva. Metin is a long-time Cochranite and had been deeply involved with Cochrane Pregnancy and Childbirth since the 1990’s. Joshua explains his first review was pretty modest (with only 3 trials) but he was hooked from there on. Joshua sat down with the Cochrane Early Career Professionals (ECP) - learn more and read his advice.

Nayaar Islam, from Canada, is a MSc Epidemiology student who was introduced to Cochrane by her graduate thesis supervisor, Dr. Matthew McInnes, who is a member of the Cochrane COVID-19 Diagnostic Test Accuracy Group. Nayaar is the lead author of the first and second updates of the Cochrane ‘living’ systematic review titled “Thoracic imaging tests for the diagnosis of COVID-19”, and she will continue to support future updates of this review. Nayaar is grateful for the opportunities she has been offered through Cochrane, such as collaborating with an international team of Cochrane scientists, being interviewed for a featured Cochrane Podcast, and of course, leading the production of high-quality evidence to inform healthcare decisions during the COVID-19 pandemic. Being a part of #TeamCochrane has been an extremely rewarding experience for Nayaar and she is excited to continue with her involvement!

Jun Xia, is based in the UK and China, and is the Co-director of the Nottingham Ningbo GRADE Centre Network and an Editor for the Cochrane Schizophrenia Group. She was introduced to Cochrane by Professor Clive Adams, the founding Editor of Cochrane Schizophrenia Group. He introduced her to the concept of evidence-based medicine, the history and mission of Cochrane, and taught her the skills of conducting a rigorous systematic review. She stayed with the Schizophrenia Group for the next 15 years and worked as a review author, trainer, and now as the Group’s Editor. A major part of her work involves bring Cochrane reviews to China, where she delivered over 80 workshops in the past decade. In 2019, together with nine other Chinese universities/hospitals, she helped to formed the Cochrane China Network, to expand the reach and advocating for evidence-based healthcare decision making. Jun spoke with the Cochrane Early Career Professionals - learn more and read her advice! 

Martin Ringsten, from Sweden, first became involved in Cochrane through a one-week systematic review course introducing the Cochrane Methodology conducted by Cochrane Sweden in 2018. The course really matched his interest in evidence-based medicine at the time. Afterwards, he started to contribute to Cochrane Sweden as a volunteer, together with his usual clinical work, further studies, and teaching at Lund University. This all led him to take a position at Cochrane Sweden in 2020 as a Project coordinator and researcher in combination with doing a PhD in Medical Science. In his current work, he initiates, organizes, and executes different projects, like organizing courses and workshops, expanding our network within Sweden and collaborating with different people and organizations to expand the reach of resources and reviews from Cochrane. For him, being able to work towards facilitating the creation and implementation of high-quality evidence in healthcare and making decisions more evidence-informed is something he values and feels truly lucky to be doing on a daily basis!

 

Eyelin Ahmadi, from Iran, is a nurse that became acquainted with Cochrane while learning about treatment options for her hospitalized patients. She soon began using Cochrane evidence to educate her patients and encouraged her colleagues to use the Cochrane Library to read the latest synthesized health evidence. Eyelin earned her Cochrane membership by translating evidence from Persian for Cochrane reviews, participating in review production by assisting with data extraction, and as a consumer peer reviewer of Cochrane reviews. She has volunteered for tasks on Cochrane TaskExchange, and she's proud to be a part of Cochrane!

Cathal Cadogan, from Ireland, is a Senior Lecturer at the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin. He is also an Associate Editor with the Effective Practice and Organisation of Care (EPOC) group. Cathal first got involved with Cochrane when he began working with Prof. Carmel Hughes as a post-doctoral research fellow in Queen’s University Belfast. Cahal remembers his first task as part of that role was to update the existing Cochrane review on interventions to improve appropriate polypharmacy for older people. The experience taught him a lot about the Cochrane review process and has helped him in conducting other systematic reviews. Cahal spoke with the Cochrane Early Career Professionals - learn more and read his advice!

Cynthia S Srikesavan, from the UK, is a Postdoctoral researcher in Physiotherapy at the University of Oxford. She has been part of Cochrane since 2013 and has contributed as a Cochrane author on two reviews. Between 2014 and 2016, she was part of Cochrane South Asia as a volunteer translator of plain language summaries and a podcast producer in Tamil. Her Cochrane translation work in Tamil was recognised at the University of Oxford’s OxTALENT annual awards 2016, and she was the runner-up for her submission "High Quality Physiotherapy Evidence in Tamil" in the Academic Podcasting category. Her video resource explaining the findings of a Cochrane review won first prize at the Cochrane UK and Ireland Symposium 2017. She is so proud to be part of Team Cochrane!

Masahiro Banno, from Nagoya, Japan, joined Cochrane in 2019 as a co-author of an ongoing Cochrane review. He is a psychiatrist and has translated more than 100 plain language summaries of Cochrane reviews from English to Japanese as a 2020 top 5 translator for Cochrane Japan, and he has reviewed more than 20 Cochrane reviews (protocols or full reviews) as a regular peer-reviewer for Cochrane Schizophrenia. He has been involved in 3 ongoing Cochrane reviews. He also worked as a lecturer for the 2019 and 2020 Cochrane Diagnostic Test Accuracy (DTA) workshops held by Cochrane Japan. This led to the development of CAST-HSROC, a software for meta-analysis of DTA, with Dr. Yuki Kataoka and Dr. Yasushi Tsujimoto, the main lecturers of the workshop, and the publication of a paper on the software. He hopes that by playing a variety of roles at Cochrane, he can broaden his horizons and contribute in some small ways to making the world a better place.

 
Nimisha Kumar,  from the United States, is a fourth-year medical student and hopeful future OB/Gyn coming off of a research year as the inaugural Cochrane Fellow of the recently established US Satellite of the Cochrane Pregnancy & Childbirth Group (US-PCG) at the Indiana University School of Medicine. During her time as the Fellow, she has worked on three PCG reviews, carried out a prioritization process, and served as liaison to the Cochrane US Network. As part of the US Network, she served as part of the Opioid Workgroup, designed to update and initiate reviews geared towards addressing the effects of the opioid epidemic in the US with regards to mothers and infants. Learn more about her story in this news item and video!

Chris Rose, from Norway, is a statistician with the Cochrane Effective Practice and Organisation of Care (EPOC) group, Norwegian Satellite. In 2018, he was appointed as a statistician at the Norwegian Institute of Public Health, with part of his salary funded to work as a statistical editor for Cochrane EPOC. Chris' Cochrane-related work is a mix of peer-reviewing (of protocols and submitted systematic reviews), consulting (performing analyses for review teams that are not supported by RevMan), and teaching (delivering training on systematic reviewing). Chris spoke with the Cochrane Early Career Professionals - learn more and read his advice!

 

Abhijna Vithal Yergolkar, from India, is a pharmacy student who learned about Cochrane from a teacher. She joined Cochrane in September 2019 when she started screening RCTs on Cochrane Crowd. To date, she has done more than 31,000 classifications and earned 6 badges, with 92-99% accuracy for RCT identification. She has taken part in 10 global challenges and completed 8 Screen 4 Me tasks, and she was one of the top three screeners in the Chile Challenge 2019. Abhijna is also a part of Cochrane TaskExchange, where she has contributed to 20 tasks and has learned a lot from participating in systematic reviews. She is currently working on a Cochrane Review for the Lung Cancer group, and she looks forward to contributing more to evidence-based medicine through this and future research. Being a part of Cochrane completely changed the way she sees evidence-based medicine and helped her to connect with researchers all around the world. She feels very fortunate and is thrilled to be a part of Cochrane!

Mohammad Shahbaz, an epidemiologist from Iran, first became involved in Cochrane by screening abstracts on Cochrane Crowd and for Screen4Me projects there. Soon, he had evaluated more than 1100 abstracts and earned his Cochrane membership! After becoming a member, he continued to contribute as part of the Crowd and has also attended methods webinars, read Cochrane reviews, and used online Cochrane learning materials. He participated in Cochrane International Mobility in Croatia under the direction of Dr. Tina Poklepović Peričić. Mohammad will begin a PhD in epidemiology and causal inference post-COVID. He is so proud to be a part of the Cochrane Community, strongly believes in the collaboration evident in Cochrane programs and tasks, and knows he is helping contribute to public health problems by being involved with Cochrane!

Fatima Abbas, from Syria, is a doctor, recently graduated from Damascus University. She has been a member of the Cochrane Community since 2014, when she joined the group now called Cochrane Gut with a group of fellow medical students from Syria, publishing a Cochrane Review protocol and working on the full Review. She later joined the Cochrane Trainers' Network and became a Cochrane champion in Syria by leading and coordinating 4 training workshops to introduce medical students and young career professionals to Cochrane, help them learn the flow of Cochrane work, how to write a systematic review protocol, and share basic knowledge about systematic reviews and meta analysis. More than 7 publications resulted from these workshops during the time of crisis in Syria, with very limited resources and a great passion to work among the working group members. She founded an educational research group in Syria through which she was promoting evidence-based medicine practice, sharing the latest evidence among residents and peer-teaching her colleagues on how to use evidence in practice. She is now in an internship program in France. She feels privileged to be a part of the Cochrane community, and hopes to connect with other colleagues in person to exchange ideas, experiences and learn from all.

René Spijker, from the Netherlands, is an Information Specialist and Senior Scientist with Cochrane Netherlands, a member of the Information Specialist Executive, a member of the Cochrane Council and  a Co-Author of the Diagnostic Test Accuracy (DTA) handbook. 

René first got involved with Cochrane as he felt he needed a career change from a molecular biology science background and applied on a joint information specialist job between Cochrane and the medical library. Reading up on Cochrane, of which he hadn’t heard before, sparked his interest as it was international, had admirable goals, was involved with science, but most importantly, also focused on the application of the outcomes. René spoke with the Cochrane Early Career Professionals - learn more and read his advice!

Hebatullah Abdulazeem, from Egypt and living in Germany, is a family physician with great interest in scientific research. She first joined Cochrane Crowd in March 2018, and within 3 months, she had classified more than 5,000 records, which were part of Crowd's 2nd birthday total of 2 Million classifications! After that very enthusiastic start, she has now completed more than 25,000 classifications, and she received her 5-year Cochrane membership with excitement. Via the Cochrane Task Exchange platform, she has been involved with more than 20 systematic reviews, and has worked with extraordinary people from all over the world. She has even tried to help other people learn about TaskExchange in her native language, Arabic. She also participated with the PICO annotators and in the QA Dashboard. She is thrilled that joining Cochrane is possible for experts or citizen scientists!

Vighnesh Devulapalli, from India, is a Third Year Medical student at Dr.NTR University of Health Sciences in Vijayawada. He joined Cochrane as a volunteer in May 2020, earning a five-year Cochrane membership from his contributions to Cochrane Crowd in just a few short months.  His contributions include a total of 20846 classification of records, with an accuracy rate of 99% in ICTRP identification, 98% in CT identification and 89% in RCT identification. Apart from that, he has participated in 4 Global Crowd Screening Challenges, including the global screening challenge on World Evidence-Based Healthcare Day, where he was one of the top screening members (screened close to half of 10,000 records), for which he received an appreciation mail and reward. He has since been inducted into a special group of screeners for Cochrane Crowd for certain screening tasks, and he continues to contribute. Vighnesh is actively completing Cochrane Interactive Learning modules and is a member of Students 4 Best Evidence (S4BE), for which he is currently drafting a blogpost.

Ana Beatriz Pizarro Nule, from Colombia, first earned her Cochrane Membership in 2018 as a Cochrane Crowd citizen scientist supporting screening challenges and by offering her skills on Cochrane Task Exchange. She represented Colombia as a content creator for the 2019 Virtual Cochrane Colloquium, has written blogs for Students for Best Evidence (S4BE), and collaborated with the Cochrane-Wikipedia partnership. This year, she became part of Cochrane Interantional Mobility with Cochrane Sweden, and shared her experience in June at the Early Career Professionals online meet-up about research collaborations. She is the Consumer Network Coordinator for Cochrane Colombia and author of an ongoing Cochrane review. She is currently serving as dissemination and outreach coordinator of the upcoming Spanish version of S4BE "Estudiantes x La Mejor Evidencia". What she values most about being a Cochrane member is that it allows her to be part of an international community that shares her passion for improving health evidence.

Chun Hoong Wong, from Malaysia, joined Cochrane in 2017 as a volunteer translator for Cochrane Malaysia. As an outpatient pharmacist at a government health clinic, Chun Hoong believes that health information should not be restricted to healthcare professionals, but needs to be accessible and comprehensible in languages that people understand. He started with the translation of podcasts and Plain Language Summaries (PLS)  from English to Malay and has now success-fully performed over 700 translations to Malay. In 2018, he expanded his translation activities to Simplified Chinese and Traditional Chinese with Cochrane China  and Cochrane Taiwan  for the translation of abstracts and/or PLS. He became the first volunteer at Cochrane First Aid in 2019, only days after the Field’s launch, and is now active as a knowledge translation product generator and translator for them, creating blogshots in English and then translating  them to the other languages in which he is fluent. More details on Chun Hoong’s Cochrane story can be found in his recent blog  for Cochrane First Aid.

Xun Li (Tina), from Beijig City, China, first joined Cochrane China back in 2007 as an undergraduate student and began to translate abstracts of Cochrane reviews. She translated more than 10 of the Cochrane review abstracts in the CAM field and published them in Chinese journals. At the same time, she joined CENTRAL database establishment by translating the citations of trials about traditional Chinese medicine that were published in Chinese. Since 2014, she has coordinated the simplified Chinese translation and dissemination of Cochrane evidence. Currently, her team has submitted more than 25000 citations to CENTRAL, and 1240 abstracts and plain language summaries of Cochrane reviews have been translated into simplified Chinese. More than 500 of these have been disseminated with China social media WeChat. She is proud to see how researchers in China have progressed in recent years; there are now more than 400 volunteers in China working for the translation and dissemination of Cochrane knowledge. 

Yasushi Tsujimoto, from Osaka City, Japan, joined Cochrane in 2019 as a part of Cochrane Japan. He is a full-time nephrologist and has been involved in more than 10 Cochrane reviews, including in Cochrane Kidney and Transplant. He has been working to promote Cochrane’s activities with social media such as Twitter or Facebook in Japan. Since he became the PR manager, Cochrane Japan’s Twitter following has increased enormously. He credits the Japanese translation team for the great job they are doing, which has led to an increase in outreach and widespread awareness. He is also interested in building on-line education system that allows health care workers to learn more effectively.

Tiffany Duque, from the United States, joined Cochrane this year as the Coordinator for the Cochrane US Network (@Cochrane_US).  She has worked in global public health for 20 years and currently lives with her family in the Los Angeles area of California.  She joined Cochrane in June and has been very impressed with the dedication, warmth, and positivity from all of the US Network members as well as from Cochrane staff.  She is thrilled to join such a reputable organization and looks forward to the opportunity to grow, create collaborations, advocate for, and promote sustainability within both the US Network and Cochrane as a whole.  If you haven’t had the chance to connect with Tiffany, she’d love to hear from you.  Here’s hoping for in-person meetings in 2021 so she can meet all of her colleagues! 

Jordi Pardo Pardo, born in Barcelona but living in Quebec, is currently Co-Managing Editor of Cochrane Musculsokeletal. Jordi joined Cochrane in November 1997. He came in as a young journalist that had no idea about health research, but he fell in love with the organization and has played many roles in it, from the Iberoamerican Cochrane Centre, the Lung Cancer Group, the Campbell and Cochrane Equity Methods Group and Cochrane Musculoskeletal. Jordi really enjoyed contributing with the first steps of the Spanish translation of reviews, and how they experimented with different processes to make the dream of having all Cochrane reviews in Spanish a reality. Jordi enjoys Colloquia so much that he helped to organize two and provided countless hours in committees for several others. Jordi also enjoyed contributing on the two waves of the Capacity Building for Managing Editors Survey. Getting an insight of the needs of those who oil the process of editing a review to get it out with the level of quality that Cochrane expects was a great opportunity to see how differently we all work, a challenge to find common ways to improve and a pleasure to see the amount of talent we have in the organization.

Roses Parker, from England, joined Cochrane in September 2019 after completing her PhD in December 2018 and having a baby in January 2019. She is the Network Support Fellow for the MOSS Network. She has enjoyed working on the Plain Language Summaries project, and completing an audit of MOSS prioritisation work. Roses is particularly proud of the citation rates for MOSS Reviews in Wikipedia and setting up the SoMe Cuppa Club for MOSS members to discuss and encourage each others’ social media use. New projects she's looking forward to include a stakeholder engagement project, increasing collaboration with Cochrane Methods and Fields, and a Network Innovation Fund project to investigate the optimal methods for the use of ‘pain’ as an outcome in systematic reviews of post-operative pain management.

Mikhail Kukushkin, from Russia, joined Cochrane in 2016. He started off contributing to Cochrane's Russian Translation Project as a volunteer translator and then as a volunteer editor, successfully reaching nearly 600 translated/edited Cochrane Plain Language Summaries. It has been a great pleasure and honor for him to work at Cochrane Russia and contribute to Russian Translations of Cochrane Evidence and to Cochrane Russia's evaluation of quality of machine translators in Memsource. He noticed that during the last 3-4 years, Cochrane’s publicity in Russia increased substantially, and he is very happy and proud of this. He hopes that in future, Cochrane's work won't face significant obstacles, both in Russia and globally, because now is not the time for misunderstanding between the participants of health care systems.

Rachel Klabunde, from Chile, joined Cochrane in 2019 helping the Cochrane Chile team to plan the 2019 Cochrane Colloquium in Santiago. She now works as part of the Community Support team in People Services and as a Communication Officer in the Knowledge Translation Department of the Cochrane Central Executive Team. Due to widespread violence and civil unrest in Santiago, the Cochrane Colloquium was canceled. Our annual event would have featured a four-day, wide-reaching scientific programme entitled ‘Embracing Diversity’ as well as a Gala Dinner open to all delegates. Due to the cancellation, all the pre-ordered food including catering provisions for a three-course Gala dinner was donated to a local charity in Santiago. Turning this negative moment into something positive is definitely something to be proud of!

Muriah Umoquit, from Canada, joined Cochrane in 2015. Working in the Knowledge Translation Department of the Central Executive Team, she  is a self-proclaimed 'Cochrane Fangirl'. Knowing how daunting rows of academic posters can be, she was thrilled to work on a project bringing branded #BetterPoster templates to disseminate Cochrane work at Colloquia and other academic conferences.  You can view many of these posters from our virtual 2019 Colloquium - including hers!

 

We want to come together and tell our collective and individual Cochrane stories! To share your #MyCochraneStory please contact support@cochrane.org with the following:

  • A photo: At your desk, at Cochrane event, or a headshot.
  • Your country of residence: Our community is diverse and we want to celebrate this!
  • Your Cochrane Story: We want to hear about  what Cochrane work and achievements you are most proud of! 3-4 sentences about yourself and your story and any URLs that could be included.
Wednesday, June 12, 2024
Rachel Klabunde
Checked
15 hours 33 minutes ago
Subscribe to Cochrane News feed